http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020230206-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9870d0666de02d7428f0757895911d3e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-542
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
filingDate 2019-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18c7c7df0367330ea0b94383f11e454c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3e9d954464071276ab3186d89e3efa6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_387d135b71a64be58ceabe2acf42e218
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e2d5e7b406cfd47f3f0ddd7743b8b1f
publicationDate 2020-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2020230206-A1
titleOfInvention Peanut oral immunotherapy dosing schedule for missed doses
abstract The present disclosure relates to improved oral immunotherapy methods for treating peanut allergy. In certain embodiments, the disclosure provides methods for continuing an oral immunotherapy for the treatment of a peanut allergy after missing a scheduled oral administration of one or more consecutive doses of a pharmaceutical composition comprising peanut protein.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11229673-B2
priorityDate 2018-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9492535-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396131
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396809
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID212810
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID212810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395920
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3100

Total number of triples: 35.